Endo Health Solutions Inc. (ENDP)
-NasdaqGS | Prev Close: | 39.30 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 36.06 |
|---|
| Beta: | 1.26 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 25.01 - 39.82 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 2,309,460 |
|---|
| Market Cap: | 4.41B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -5.58 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Endo Health Solutions Larger Than S&P 500 Component Avery Dennisonat Forbes(Fri, Jun 14)
- What are hedge funds buying these days?at MarketWatch(Fri, Jun 14)
- Endo Health Reaches New 52-Week High (ENDP)at TheStreet(Fri, Jun 14)
- Crucial Junctures May Offer Opportunity to These Companiesat Motley Fool(Thu, Jun 13)
- ENDO HEALTH SOLUTIONS INC. Files SEC form 8-K, Costs Associated with Exit or Disposal ActivitiesEDGAR Online(Mon, Jun 10)
- Endo Health Reaches New 52-Week High (ENDP)at TheStreet(Fri, Jun 7)
- Endo to Trim WorkforceZacks(Thu, Jun 6)
- Analysts: Abbott Labs EPS Will Grow and 3 More Research Notes to Exploreat Wall St. Cheat Sheet(Thu, Jun 6)
- Endo Stock Up As Analysts Debate Restructuring Planat Investor's Business Daily(Thu, Jun 6)
- Analyst Moves: SWFT, ENDP, CLVSat Forbes(Thu, Jun 6)
- Ahead of the Bell: Analyst downgrades Endo HealthAP(Thu, Jun 6)
- Analysts' Actions: CLVS ENDP THC WRBTheStreet(Thu, Jun 6)
- Endo Health Solutions' CEO Hosts Update Conference (Transcript)at Seeking Alpha(Thu, Jun 6)
- Endo Health downgraded by Cantor FitzgeraldBriefing.com(Wed, Jun 5)
- Endo Health to slash 15 pct jobs, looks to sell some assetsat Reuters(Wed, Jun 5)
Comparison
| Symbol | % Chg | Mkt Cap |
|---|
| ENDP | 0.00% | 4.41B |
| NVO | 0.00% | 87.58B |
| TEVA | 0.00% | 33.50B |
| AGN | 0.00% | 30.08B |
| FRX | 0.00% | 11.01B |
Key Statistics
| Forward P/E (1 yr): | 10.45 |
|---|
| P/S (ttm): | 1.45 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 4.32 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.15 |
|---|
| Mean Recommendation*: | 2.6 |
|---|
| PEG Ratio (5 yr expected): | 4.87 |
|---|
Business Summary
Endo Health Solutions Inc. provides specialty healthcare solutions in the United States and internationally. The company’s Endo Pharmaceuticals segment offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltare...
View More